Softening EpCAM− cells (non-CSCs) increased the EpCAM+ fraction (CSCs) by 40 to 84% (Fig. S14A) and the formation and growth of tumor spheroids by 150 to 250% (Fig. S14B) and 230 to 300% (Fig. S14C), respectively. This evidence concerns the gene EPCAM and neoplasm.